ALKS33

RDC-0313 · Alkermes, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALKS33, covering 2011-08-23 to 2011-08-23. Get the full timeline:

Most recent: Clinical Trial Update: ALK33-005: A Study of ALKS33 (RDC-0313) in Adults With Alcohol Dependence [Phase 2]